Stevanato Group S.p.A (STVN) Net Cash Flow Growth (1y) (2021 - 2026)
Stevanato Group S.p.A (STVN) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.02 Bn | 120.80 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 44.98 Bn | 44.16 Bn | 2.15 Bn | 131.47% |
| 3 | Alcon | 33.07 Bn | 31.41 Bn | 1.53 Bn | - |
| 4 | Medline | 33.03 Bn | 30.80 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 29.47 Bn | 27.81 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 23.28 Bn | 22.84 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -41.07% |
| 8 | Cooper Companies | 13.93 Bn | 13.79 Bn | 735.40 Mn | 102.38% |
| 9 | Align Technology | 12.10 Bn | 11.04 Bn | 736.59 Mn | 84.02% |
| 10 | Stevanato Group S.p.A | 5.43 Bn | 5.28 Bn | 88.01 Mn | -233.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -233.51% |
| Dec 31, 2025 | -2.16% |
| Sep 30, 2025 | 14,632.53% |
| Jun 30, 2025 | 106.35% |
| Mar 31, 2025 | -105.50% |
| Dec 31, 2024 | 233.74% |
| Sep 30, 2024 | -95.53% |
| Jun 30, 2024 | 4.86% |
| Mar 31, 2024 | 268.87% |
| Dec 31, 2023 | 121.37% |
| Sep 30, 2023 | 105.69% |
| Jun 30, 2023 | -112.94% |
| Mar 31, 2023 | -43.75% |
| Dec 31, 2022 | -36.51% |
| Sep 30, 2022 | -114.90% |
| Jun 30, 2022 | -337.23% |
| Mar 31, 2022 | -18.88% |
| Dec 31, 2021 | -720.23% |
| Sep 30, 2021 | 3,725.10% |
| Jun 30, 2021 | -69.59% |